Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 09, 2024

SELL
$1.2 - $2.13 $46,616 - $82,744
-38,847 Reduced 62.13%
23,678 $43,000
Q3 2023

Nov 13, 2023

BUY
$1.04 - $1.74 $65,026 - $108,793
62,525 New
62,525 $103,000
Q1 2023

May 12, 2023

BUY
$1.52 - $2.5 $49,992 - $82,225
32,890 New
32,890 $61,000
Q2 2022

Aug 12, 2022

BUY
$1.32 - $2.12 $14,526 - $23,330
11,005 New
11,005 $18,000

Others Institutions Holding BDSX

About BIODESIX INC


  • Ticker BDSX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 39,982,000
  • Market Cap $55.2M
  • Description
  • Biodesix, Inc. operates as a data-driven diagnostic solutions company in the United States. The company offers blood-based lung tests, including Nodify XL2 and Nodify CDT tests, together marketed as part of Nodify Lung Nodule Risk Assessment testing strategy, to assess the risk of lung cancer and help in identifying the appropriate treatment pat...
More about BDSX
Track This Portfolio

Track Hrt Financial LP Portfolio

Follow Hrt Financial LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hrt Financial LP, based on Form 13F filings with the SEC.

News

Stay updated on Hrt Financial LP with notifications on news.